Skip to main content

Warning notification:Warning

Unfortunately, you are using an outdated browser. Please, upgrade your browser to improve your experience with HSE. The list of supported browsers:

  1. Chrome
  2. Edge
  3. FireFox
  4. Opera
  5. Safari
HSE National Clinical Guideline

HSE National Clinical Guideline: Active surveillance for patients with prostate cancer


Topic: Prostate cancer active surveillance
Document Owner: Head of evidence and quality hub, national cancer control programme (nccp)
National Group: National cancer control programme
Effective From: 15 May 2025
Evidence-based recommendations on the active surveillance of patients with prostate cancer
HSE National Clinical Guideline: Active surveillance for patients with prostate cancer
PDF, 0.69MB

The purpose of this National Clinical Guideline is to provide evidence-based recommendations on the active surveillance of patients with prostate cancer through the integration of the best research evidence with clinical expertise, patient values and experiences.

Back to HSE National Central Repository